ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,157.43 | 7,827.18 | 3,792.15 | 15,608.74 | 22,753.71 | 12,814.54 | 4,232.16 | – | 2,053.60 | – | 160.68 | 45.79 | 32.48 | – | – | – | – | – | 0.00 | 0.00 | 18.61 | 0.00 | |
| – | – | – | – | – | – | – | 9,035.04 | – | – | – | 108.10 | 40.45 | 3.45 | 2.93 | 6.46 | 6.26 | 6.04 | 3.53 | – | – | – | |
| – | – | – | – | – | – | – | -9,035.04 | – | – | – | -62.32 | -7.97 | -3.45 | -2.93 | -6.46 | -6.26 | -6.04 | -3.53 | – | 18.61 | – | |
| 74,435.42 | 88,749.97 | 89,093.69 | 62,867.90 | 87,913.60 | 109,690.68 | 79,728.14 | 47,219.11 | 26,350.21 | 12,316.00 | 5,364.65 | 2,789.03 | 904.98 | 1,450.00 | 277.93 | 298.73 | 159.99 | 144.01 | 120.48 | 36.79 | 10.47 | 2.72 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 54.29 | 37.19 | 15.36 | 3.01 | |
| 234,366.53 | 213,088.17 | 196,012.23 | 179,751.72 | 197,251.72 | 207,266.92 | 146,915.24 | 71,312.92 | 51,672.33 | 27,646.43 | 10,721.27 | 4,616.52 | 1,600.54 | 1,799.54 | 634.23 | 577.94 | 316.54 | 260.29 | 171.24 | 73.98 | 25.83 | 5.74 | |
| -235,321.88 | -207,998.56 | -194,501.76 | -172,788.76 | -179,323.47 | -199,659.88 | -146,509.16 | -80,347.96 | -52,268.11 | -29,537.52 | -11,122.42 | -4,678.84 | -1,608.50 | -1,802.99 | -637.16 | -584.40 | -322.80 | -266.33 | -174.77 | -73.98 | -7.22 | -5.74 | |
| – | – | – | – | 54,953.51 | 69,209.88 | 323,538.06 | 1,404.35 | 1,304.72 | 788.65 | 137.59 | 1.69 | – | 59.07 | 0.09 | 18.68 | 15.45 | 7.92 | 9.90 | 4.93 | 3.35 | 0.93 | |
| -213,769.58 | -186,532.12 | -188,560.01 | -169,182.99 | -229,272.05 | -266,862.49 | -404,580.20 | -92,257.60 | -52,019.03 | -39,431.58 | -14,823.22 | -11,027.95 | -3,875.24 | -1,875.85 | -638.41 | -588.09 | -379.16 | -419.65 | -183.52 | -72.98 | -9.20 | -5.34 | |
| – | – | – | – | – | – | – | – | – | – | – | – | -294.50 | – | 1.65 | – | – | – | -0.39 | – | – | – | |
| -213,769.58 | -186,532.12 | -188,560.01 | -169,182.99 | -229,272.05 | -266,862.49 | -404,580.20 | -92,257.60 | -52,019.03 | -39,431.58 | -14,823.22 | -11,027.95 | -3,580.74 | -1,875.85 | -640.07 | -588.09 | -379.16 | -419.65 | -183.13 | -72.98 | -9.20 | -5.34 | |
| -233,209.10 | -205,260.99 | -192,220.08 | -164,142.98 | -174,498.01 | -194,452.38 | -142,683.07 | -78,529.53 | -49,618.73 | -27,646.43 | -10,560.59 | -4,570.73 | -1,568.05 | -1,799.54 | -634.23 | -577.94 | -316.54 | -405.70 | -170.10 | -64.59 | -5.37 | -4.41 |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.